Share Twitter LinkedIn Facebook Email Jeanny B. Aragon-Ching, MD, FACP, discusses the 2nd line treatment options in RCC after I-O failure at Annual Meeting 2018. Advertisement
Alcohol Consumption and Cancer Risk: Insights from the 2025 Surgeon Generalโs Advisory Breast Cancer 3 Mins Read
Genitourinary Cancer [2025] Treatment Breakthroughs: ASCO GU 2025 Highlights Nataliya Mar, MD – MOASC Genitourinary 6 Mins Read
